TELO Publishes Peer-Reviewed Telomir-Zn Data Showing Dose-Dependent Survival Improvement, Reduced Hepatic Copper Burden in Wilson's Disease Study
Telomir Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $1.30
-1.5% in 3d after detection
Post-detection moves
1h
—
1d
-0.8%
3d
-1.5%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS